Sepsis Clinical Trials
36 studies are recruiting for sepsis in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…
- Stage
- Phase 2
- Ages
- 18 to 80
- Site
- Research Site, Newport Beach, California
- Locations
- 74 in total
- Run by
- AstraZeneca
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
The long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients. The central hypothesis is that a threshold burden of SnCs predisposes to a SASP mediated dysfunctional response to PAMPs, contributing to a disproportionate …
- Stage
- Phase 2
- Ages
- 65 and older
- Site
- University of Iowa, Iowa City, Iowa
- Locations
- 10 in total
- Run by
- University of Minnesota
-
MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
This study is being done to determine if early administration of Midodrine can improve outcomes by maintaining a higher mean blood pressure off of intravenous medications. Researchers want to see if Midodrine can help people with sepsis need fewer vasopressors, which could mean shorter hospital sta…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Mayo Clinic Arizona, Scottsdale, Arizona
- Locations
- 5 in total
- Run by
- Mayo Clinic
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
The goal of the CASPER-Pilot study is to develop clinical decision support (CDS) technology within Epic to randomize patients with septic shock to early versus standard of care vasopressin initiation. The primary aim of this study will be to test the hypothesis that CDS technology can be utilized t…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Cleveland Clinic, Cleveland, Ohio
- Run by
- The Cleveland Clinic
-
Personalized Fluid Resuscitation in the Emergency Department: A Pilot Trial
The goal of this pilot clinical trial is to learn if a fluid assessment using non-invasive cardiac output monitoring (NICOM) is helpful for patients with sepsis who have low blood pressure in the Emergency Department (ED). The study will measure whether the NICOM assessment changes fluid resuscitat…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Intermountain Medical Center Emergency Department, Murray, Utah
- Run by
- Intermountain Health Care, Inc.
-
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
Adverse outcomes in surgical sepsis patients are secondary to dysregulated emergency myelopoiesis, and expansion of myeloid-derived suppressor cells. Here we propose to determine the underlying mechanisms behind the increased expansion of these leukocyte populations and the underlying mechanisms th…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- UF Health at Shands hospital, Gainesville, Florida
- Run by
- University of Florida
-
The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. Both combinations are approved by the Food and Drug Administration (FDA). The goal is to help doctors know which combination is safer so the…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Bassett Medical Center, Cooperstown, New York
- Locations
- 3 in total
- Run by
- Bassett Healthcare
-
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
Study Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all-cause late onset sepsis (LOS) without increasing the risk of other adverse outcomes. Study Design …
- Stage
- Phase 2
- Ages
- 0 to 2
- Site
- St. Joseph's Medical Center, Tacoma, Washington
- Locations
- 6 in total
- Run by
- University of Washington
-
Evaluation of Pediatric eCART Implementation
This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to…
- Stage
- Not phased
- Ages
- Up to 17
- Site
- American Family Children's Hospital, Madison, Wisconsin
- Run by
- University of Wisconsin, Madison
-
An Acupuncture Study for People At High Risk for Sepsis
Researchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sham acupuncture. Sha…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Susan Samueli Integrative Health Institute, University of California, Irvine, Irvine, California
- Run by
- University of California, Irvine
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These patients are already on ventilators, which means they need suctioning to keep their airways clear, but this procedure may be…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Loma Linda University Medical Center Troesh Medical Campus, Loma Linda, California
- Run by
- Loma Linda University
-
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 3 in total
- Run by
- Health Discovery Labs
-
Smart Discharges for Older Children
This study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are discharged in East Africa. In low- and middle-income countries, about …
- Stage
- Not phased
- Ages
- 5 to 16
- Site
- The Rwanda Paediatric Association, Kigali,
- Locations
- 7 in total
- Run by
- University of British Columbia
-
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
The aim of this project is to test the utility of The Gene Z device (as of 2018 Gene Z no longer being used), now using In-Dx and other rapid identification techniques that the investigators have developed in the lab on clinically obtained bodily fluid samples taken from patients with suspected inf…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Michigan Health/Sparrow (name change only), Lansing, Michigan
- Locations
- 2 in total
- Run by
- Michigan State University
-
Recovery of Physical Function After Critical Illness In Older Adults
The proposed study is a prospective, observational study assessing the recovery of muscle and physical function in patients surviving critical illness (n =150) at hospital discharge (baseline) and repeated serially. Patients will be enrolled after life-saving modalities have been weaned near hospit…
- Stage
- Not phased
- Ages
- 18 to 99
- Site
- University of Kentucky, Lexington, Kentucky 40536, Lexington, Kentucky
- Run by
- University of Kentucky
-
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
The goal of this clinical trial is to determine if vancomycin dosing in children with sepsis can be improved by using updated, personalized dosing models that account for new markers of an individual's kidney function. Vancomycin is prescribed based on the known information of how the body breaks t…
- Stage
- Phase 1
- Ages
- 0 to 17
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Run by
- Children's Hospital of Philadelphia
-
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study i…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Maryland Medical Center - Midtown, Baltimore, Maryland
- Locations
- 8 in total
- Run by
- University of Maryland, Baltimore
-
Biomarkers in Infection
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Beth Israel Deaconess Medical Center
-
Assessing Immune Dysfunction in Sepsis
Sepsis leads to sustained immune system dysfunction resulting in increased susceptibility to secondary infection while in the hospital or after discharge. Consequently, many of the ~2 million Americans that develop sepsis every year will end up back in the ICU, weeks and months later. The objective…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Minnesota, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
In this research study we want to learn more about the characteristics of neutrophils that are present in the blood and secretions from a breathing tube of patients with sepsis. Sepsis is a severe type of infection, affecting various parts of the body. Neutrophils are a type of white blood cell tha…
- Stage
- Not phased
- Ages
- 2 to 50
- Site
- Boston Children's Hospital, Boston, Massachusetts
- Run by
- Boston Children's Hospital
-
Safe and Explainable AI
While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical know…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- Abramson Cancer Center at Penn Medicine
-
The APS Phenotyping Study
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Fresno Community Hospital and Medical Center, Fresno, California
- Locations
- 20 in total
- Run by
- Vanderbilt University Medical Center
-
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at capture and interpretation of a complex set of tests, administered during a subject's sepsis functional recovery trajectory, …
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
To demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines. To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical intensive care patient…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
BLOOM: Pragmatic Feasibility Trial
The goal of this study is to compare two different ways of dosing cefepime, an antibiotic for very sick patients - the usual approach to dosing or a new dosing method. The new dosing method uses only doses that are available in normal care, but choosing between the different doses is based on more …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Run by
- Mayo Clinic
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.